Update on the main MDR pathogens: prevalence and treatment options

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Background:

• Multi-drug resistance (MDR) in bacterial pathogens is a significant global health concern.
• Infections acquired in healthcare settings are particularly challenging due to rising MDR rates.
• The ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) are key players in nosocomial infections.

Purpose of the Study:

• To review the increasing prevalence of MDR among ESKAPE pathogens over time.
• To present global data on the current burden of MDR infections caused by these bacteria.
• To highlight the public health threat posed by limited treatment options.

Main Methods:

• Literature review of studies on antimicrobial resistance in ESKAPE pathogens.
• Analysis of trends in MDR prevalence across different continents.
• Synthesis of data on the clinical impact and burden of these infections.

Main Results:

• ESKAPE pathogens demonstrate a worrying worldwide increase in multi-drug resistance.
• Data from all continents indicate a substantial and growing prevalence of MDR in these bacteria.
• The rise in resistance limits effective therapeutic strategies for nosocomial infections.

Conclusions:

• MDR in ESKAPE pathogens represents a critical and escalating threat to public health.
• Urgent global strategies are needed to combat the spread and impact of these resistant bacteria.
• Continued surveillance and research are essential to address this challenge.